Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Pfizer, Arvinas' breast cancer med wins FDA approval
Pfizer and Arvinas will leave commercialization of the drug to a yet-to-be-identified partner, the companies have said.
Zoey Becker
May 1, 2026 3:50pm
In another win for rare disease, Travere nabs FDA’s first FSGS nod
Apr 13, 2026 6:25pm
AZ nabs Calquence fixed-duration nod to counter BeOne’s CLL push
Feb 20, 2026 11:05am
2025 approvals: Biopharma delivered 55 new drugs, biologics
Jan 5, 2026 3:00am
Vanda, Agios score holiday season FDA approvals
Jan 2, 2026 11:33am
FDA signs off on 1st gene therapy for rare genetic disease
Dec 10, 2025 12:09pm